RNA Therapy Reduces Muscle Loss from Obesity Medications by 50%
Administering an experimental small interfering RNA therapy alongside the GLP-1 drug semaglutide cuts muscle loss by nearly half while enhancing fat reduction in mice, according to a study published September 22 in the Proceedings of the National Academy of Sciences. Developed by researchers at the Northwestern University Feinberg School of Medicine and biotech firm Ionis … Read more